Literature DB >> 23453346

The final chapter of the ALS lithium saga.

Adriano Chiò1, Gabriele Mora.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23453346     DOI： 10.1016/S1474-4422(13)70040-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  4 in total

Review 1.  Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.

Authors:  O V Forlenza; V J R De-Paula; B S O Diniz
Journal:  ACS Chem Neurosci       Date:  2014-05-06       Impact factor: 4.418

2.  Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study.

Authors:  Orestes V Forlenza; Artur Martins Novaes Coutinho; Ivan Aprahamian; Silvana Prando; Luciana Lucas Mendes; Breno S Diniz; Wagner F Gattaz; Carlos A Buchpiguel
Journal:  ACS Chem Neurosci       Date:  2014-04-29       Impact factor: 4.418

3.  Research led by participants: a new social contract for a new kind of research.

Authors:  Effy Vayena; Roger Brownsword; Sarah Jane Edwards; Bastian Greshake; Jeffrey P Kahn; Navjoyt Ladher; Jonathan Montgomery; Daniel O'Connor; Onora O'Neill; Martin P Richards; Annette Rid; Mark Sheehan; Paul Wicks; John Tasioulas
Journal:  J Med Ethics       Date:  2015-03-30       Impact factor: 2.903

Review 4.  A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts.

Authors:  Liliana Dell'Osso; Claudia Del Grande; Camilla Gesi; Claudia Carmassi; Laura Musetti
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-11       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.